Karyopharm Therapeutics Inc. Business Finance Contracts & Agreements

44 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Karyopharm Therapeutics Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2025
Second Amendment to Revenue Interest Financing Agreement by and among Karyopharm Therapeutics Inc. and Healthcare Royalty Partners
Financing Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2023
Common Stock Purchase Warrant Agreement between Karyopharm Therapeutics Inc. and Healthcare Royalty Partners III, L.P.
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2023
Karyopharm Therapeutics Inc. Performance-Vested Restricted Stock Unit Agreement under 2022 Equity Incentive Plan
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2023
Registration Rights Agreement between Karyopharm Therapeutics Inc. and Investors (December 5, 2022)
Registration Rights Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Securities Purchase Agreement between Karyopharm Therapeutics Inc. and Investors (December 5, 2022)
Purchase Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Common Stock Purchase Warrant Agreement between Karyopharm Therapeutics Inc. and Holder (December 7, 2022)
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Karyopharm Therapeutics Inc. Restricted Stock Unit Agreement (Time Vested) under 2022 Equity Incentive Plan
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2022
Karyopharm Therapeutics Inc. Stock Option Agreement under 2022 Equity Incentive Plan
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2022
First Amendment to Asset Purchase Agreement between Biogen MA Inc. and Karyopharm Therapeutics Inc.
Purchase Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2021
Omnibus Amendment to Revenue Interest Financing and Related Agreements by Karyopharm Therapeutics and Healthcare Royalty Partners
Modification Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2021
Description of Karyopharm Therapeutics Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2021
Karyopharm Therapeutics Inc. 2020 Israeli Equity Incentive Sub Plan Restricted Stock Unit Agreement (Time Vested)
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Karyopharm Therapeutics Inc. 2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Karyopharm Therapeutics Inc. Incentive Stock Option Agreement under 2013 Stock Incentive Plan
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Amendment No. 1 to Open Market Sale Agreement between Karyopharm Therapeutics Inc. and Jefferies LLC
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Description of Karyopharm Therapeutics Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Revenue Interest Financing Agreement between Karyopharm Therapeutics Inc. and Healthcare Royalty Partners III, L.P. & IV, L.P. (September 14, 2019)
Financing Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2019
Karyopharm Therapeutics Inc. Nonstatutory Stock Option Agreement (Inducement Grant) with Michael Mason
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2019
Indenture for 3.00% Convertible Senior Notes due 2025 between Karyopharm Therapeutics Inc. and Wilmington Trust, N.A.
Indenture Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2018
Open Market Sale Agreement between Karyopharm Therapeutics Inc. and Jefferies LLC (August 17, 2018)
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2018
Parent Company Guarantee for License Agreement between Karyopharm Therapeutics Inc. and Antengene Therapeutics Limited
Guaranty Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2018
Karyopharm Therapeutics Inc. Nonstatutory Stock Option Agreement (Inducement Grant) with Participant
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2018
Asset Purchase Agreement between Biogen MA Inc. and Karyopharm Therapeutics Inc. dated January 24, 2018
Purchase Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2018
Amendment No. 2 to Sales Agreement between Karyopharm Therapeutics Inc. and Cantor Fitzgerald & Co.
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2017
Amendment No. 1 to Sales Agreement between Karyopharm Therapeutics Inc. and Cantor Fitzgerald & Co.
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2016
Controlled Equity Offering Sales Agreement between Karyopharm Therapeutics Inc. and Cantor Fitzgerald & Co. (December 7, 2015)
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2015
Karyopharm Therapeutics Inc. Restricted Stock Unit Agreement under 2013 Stock Incentive Plan
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2015
Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan
Equity Distribution Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2013
Karyopharm Therapeutics Inc. 2022 Israeli Equity Incentive Sub Plan Option Agreement
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2022
Karyopharm Therapeutics Inc. Nonstatutory Stock Option Agreement under 2022 Inducement Stock Incentive Plan
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2022
Karyopharm Therapeutics Inc. 2020 Israeli Equity Incentive Sub Plan Option Agreement with Participant
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Karyopharm Therapeutics Inc. Nonstatutory Stock Option Agreement (Inducement Grant)
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2020
Karyopharm Therapeutics Inc. Nonstatutory Stock Option Agreement under 2013 Stock Incentive Plan
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Underwriting Agreement between Karyopharm Therapeutics Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and Jefferies LLC for 6,250,000 Shares of Common Stock
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2020
Karyopharm Therapeutics Inc. Underwriting Agreement for 9,152,543 Shares of Common Stock with J.P. Morgan, Jefferies, and Leerink Partners
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2018
Karyopharm Therapeutics Inc. Nonstatutory Stock Option Agreement with Michael Falvey
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2017
Underwriting Agreement between Karyopharm Therapeutics Inc. and Cantor Fitzgerald & Co. for Sale of Common Stock
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2017
Underwriting Agreement for 3,000,000 Shares of Common Stock by Karyopharm Therapeutics Inc. and Selling Shareholders with Merrill Lynch and J.P. Morgan as Representatives of the...
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2015
Karyopharm Therapeutics Inc. Underwriting Agreement with Merrill Lynch, Leerink Partners, and Other Underwriters (2014)
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2014